Drospirenone is a synthetic progestogen with anti-androgenic and anti-mineralocorticoid properties that may potentially modulate neurogenic inflammation and neurovascular mechanisms associated with Cluster Headache. While not a primary treatment for Cluster Headache, its hormonal effects could theoretically influence pain pathways and vascular reactivity, though more research is needed to establish its definitive therapeutic role.